Summary

According to our LPI (LP Information) latest study, the global Nicotinamide Riboside (NR) market size was valued at US$ 21 million in 2022. With growing demand in downstream market, the Nicotinamide Riboside (NR) is forecast to a readjusted size of US$ 37 million by 2029 with a CAGR of 8.6% during review period.
The research report highlights the growth potential of the global Nicotinamide Riboside (NR) market. Nicotinamide Riboside (NR) are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Nicotinamide Riboside (NR). Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Nicotinamide Riboside (NR) market.
Nicotinamide riboside (NR) is claimed to be a new form pyridine-nucleoside of vitamin B3 that functions as a precursor to nicotinamide adenine dinucleotide or NAD+. Nicotinamide Riboside(NR) is white or light yellow crystalline powder, odorless, bitter and slightly hygroscopic.
In fact, the market’s mainstream is selling NRC powder, the full name called nicotinamide riboside chloride. NRC is a chloride form of NR. 100 mg of nicotinamide riboside chloride provides about 88 mg of nicotinamide riboside. The report focuses on the Nicotinamide Riboside(NR) market, which has been converted.
The global Nicotinamide Riboside (NR) market was valued at US$ 21.46 million in 2022 and will reach US$ 38.76 million by the end of 2029, growing at a CAGR of 8.32% during 2023-2029.
The data for 2023 is an estimate, based on the historical data and the integrated view of industrial experts, manufacturers, distributors, and end users, etc.
Top-down and bottom-up approaches are used to validate the global Nicotinamide Riboside (NR) market size and to estimate the market size for company, regional division, product type and application (end users). In the complete market engineering process, both top-down and bottom-up approaches along with several data triangulation methods have been extensively utilized to perform market estimation and market forecast for the overall market division and subdivision listed in this report. Extensive qualitative and further quantitative analysis has also been done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.
Global key players of Nicotinamide Riboside (NR) include ChromaDex, Genex Formulas, Shandong Tianming Pharmaceutical, Bontac, Longer Livetech, etc. The top three players hold a share over 60%.
Asia-Pacific is the largest market, has a share about 39%, followed by North America, and Europe, with share 35% and 16%, separately.
In terms of product type, purity below 98% is the largest segment, occupied for a share of 63%, and in terms of application, health supplement has a share about 92 percent.
Key Features:
The report on Nicotinamide Riboside (NR) market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Nicotinamide Riboside (NR) market. It may include historical data, market segmentation by Type (e.g., Purity ≤98%, Purity ＞98%), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Nicotinamide Riboside (NR) market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Nicotinamide Riboside (NR) market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Nicotinamide Riboside (NR) industry. This include advancements in Nicotinamide Riboside (NR) technology, Nicotinamide Riboside (NR) new entrants, Nicotinamide Riboside (NR) new investment, and other innovations that are shaping the future of Nicotinamide Riboside (NR).
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Nicotinamide Riboside (NR) market. It includes factors influencing customer ' purchasing decisions, preferences for Nicotinamide Riboside (NR) product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Nicotinamide Riboside (NR) market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Nicotinamide Riboside (NR) market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Nicotinamide Riboside (NR) market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Nicotinamide Riboside (NR) industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Nicotinamide Riboside (NR) market.
Market Segmentation:
Nicotinamide Riboside (NR) market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Segmentation by type
Purity ≤98%
Purity ＞98%
Segmentation by application
Health Supplement
Pharmaceutical Additives
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
ChromaDex
Genex Formulas
Shandong Tianming Pharmaceutical
Bontac
Longer Livetech
Tiantai Biotechnology
EnzymeWorks
Suzhou MyLand Pharm & Nutrition
Shenzhen Ejion Biotechnology
Zhejiang Jiahua
Weitai Pharmaceutical
Key Questions Addressed in this Report
What is the 10-year outlook for the global Nicotinamide Riboside (NR) market?
What factors are driving Nicotinamide Riboside (NR) market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Nicotinamide Riboside (NR) market opportunities vary by end market size?
How does Nicotinamide Riboside (NR) break out type, application?

ページTOPに戻る

Table of Contents

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Nicotinamide Riboside (NR) Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Nicotinamide Riboside (NR) by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Nicotinamide Riboside (NR) by Country/Region, 2018, 2022 & 2029
2.2 Nicotinamide Riboside (NR) Segment by Type
2.2.1 Purity ≤98%
2.2.2 Purity ＞98%
2.3 Nicotinamide Riboside (NR) Sales by Type
2.3.1 Global Nicotinamide Riboside (NR) Sales Market Share by Type (2018-2023)
2.3.2 Global Nicotinamide Riboside (NR) Revenue and Market Share by Type (2018-2023)
2.3.3 Global Nicotinamide Riboside (NR) Sale Price by Type (2018-2023)
2.4 Nicotinamide Riboside (NR) Segment by Application
2.4.1 Health Supplement
2.4.2 Pharmaceutical Additives
2.5 Nicotinamide Riboside (NR) Sales by Application
2.5.1 Global Nicotinamide Riboside (NR) Sale Market Share by Application (2018-2023)
2.5.2 Global Nicotinamide Riboside (NR) Revenue and Market Share by Application (2018-2023)
2.5.3 Global Nicotinamide Riboside (NR) Sale Price by Application (2018-2023)
3 Global Nicotinamide Riboside (NR) by Company
3.1 Global Nicotinamide Riboside (NR) Breakdown Data by Company
3.1.1 Global Nicotinamide Riboside (NR) Annual Sales by Company (2018-2023)
3.1.2 Global Nicotinamide Riboside (NR) Sales Market Share by Company (2018-2023)
3.2 Global Nicotinamide Riboside (NR) Annual Revenue by Company (2018-2023)
3.2.1 Global Nicotinamide Riboside (NR) Revenue by Company (2018-2023)
3.2.2 Global Nicotinamide Riboside (NR) Revenue Market Share by Company (2018-2023)
3.3 Global Nicotinamide Riboside (NR) Sale Price by Company
3.4 Key Manufacturers Nicotinamide Riboside (NR) Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Nicotinamide Riboside (NR) Product Location Distribution
3.4.2 Players Nicotinamide Riboside (NR) Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Nicotinamide Riboside (NR) by Geographic Region
4.1 World Historic Nicotinamide Riboside (NR) Market Size by Geographic Region (2018-2023)
4.1.1 Global Nicotinamide Riboside (NR) Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Nicotinamide Riboside (NR) Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Nicotinamide Riboside (NR) Market Size by Country/Region (2018-2023)
4.2.1 Global Nicotinamide Riboside (NR) Annual Sales by Country/Region (2018-2023)
4.2.2 Global Nicotinamide Riboside (NR) Annual Revenue by Country/Region (2018-2023)
4.3 Americas Nicotinamide Riboside (NR) Sales Growth
4.4 APAC Nicotinamide Riboside (NR) Sales Growth
4.5 Europe Nicotinamide Riboside (NR) Sales Growth
4.6 Middle East & Africa Nicotinamide Riboside (NR) Sales Growth
5 Americas
5.1 Americas Nicotinamide Riboside (NR) Sales by Country
5.1.1 Americas Nicotinamide Riboside (NR) Sales by Country (2018-2023)
5.1.2 Americas Nicotinamide Riboside (NR) Revenue by Country (2018-2023)
5.2 Americas Nicotinamide Riboside (NR) Sales by Type
5.3 Americas Nicotinamide Riboside (NR) Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Nicotinamide Riboside (NR) Sales by Region
6.1.1 APAC Nicotinamide Riboside (NR) Sales by Region (2018-2023)
6.1.2 APAC Nicotinamide Riboside (NR) Revenue by Region (2018-2023)
6.2 APAC Nicotinamide Riboside (NR) Sales by Type
6.3 APAC Nicotinamide Riboside (NR) Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Nicotinamide Riboside (NR) by Country
7.1.1 Europe Nicotinamide Riboside (NR) Sales by Country (2018-2023)
7.1.2 Europe Nicotinamide Riboside (NR) Revenue by Country (2018-2023)
7.2 Europe Nicotinamide Riboside (NR) Sales by Type
7.3 Europe Nicotinamide Riboside (NR) Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Nicotinamide Riboside (NR) by Country
8.1.1 Middle East & Africa Nicotinamide Riboside (NR) Sales by Country (2018-2023)
8.1.2 Middle East & Africa Nicotinamide Riboside (NR) Revenue by Country (2018-2023)
8.2 Middle East & Africa Nicotinamide Riboside (NR) Sales by Type
8.3 Middle East & Africa Nicotinamide Riboside (NR) Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Nicotinamide Riboside (NR)
10.3 Manufacturing Process Analysis of Nicotinamide Riboside (NR)
10.4 Industry Chain Structure of Nicotinamide Riboside (NR)
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Nicotinamide Riboside (NR) Distributors
11.3 Nicotinamide Riboside (NR) Customer
12 World Forecast Review for Nicotinamide Riboside (NR) by Geographic Region
12.1 Global Nicotinamide Riboside (NR) Market Size Forecast by Region
12.1.1 Global Nicotinamide Riboside (NR) Forecast by Region (2024-2029)
12.1.2 Global Nicotinamide Riboside (NR) Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Nicotinamide Riboside (NR) Forecast by Type
12.7 Global Nicotinamide Riboside (NR) Forecast by Application
13 Key Players Analysis
13.1 ChromaDex
13.1.1 ChromaDex Company Information
13.1.2 ChromaDex Nicotinamide Riboside (NR) Product Portfolios and Specifications
13.1.3 ChromaDex Nicotinamide Riboside (NR) Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 ChromaDex Main Business Overview
13.1.5 ChromaDex Latest Developments
13.2 Genex Formulas
13.2.1 Genex Formulas Company Information
13.2.2 Genex Formulas Nicotinamide Riboside (NR) Product Portfolios and Specifications
13.2.3 Genex Formulas Nicotinamide Riboside (NR) Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Genex Formulas Main Business Overview
13.2.5 Genex Formulas Latest Developments
13.3 Shandong Tianming Pharmaceutical
13.3.1 Shandong Tianming Pharmaceutical Company Information
13.3.2 Shandong Tianming Pharmaceutical Nicotinamide Riboside (NR) Product Portfolios and Specifications
13.3.3 Shandong Tianming Pharmaceutical Nicotinamide Riboside (NR) Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Shandong Tianming Pharmaceutical Main Business Overview
13.3.5 Shandong Tianming Pharmaceutical Latest Developments
13.4 Bontac
13.4.1 Bontac Company Information
13.4.2 Bontac Nicotinamide Riboside (NR) Product Portfolios and Specifications
13.4.3 Bontac Nicotinamide Riboside (NR) Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Bontac Main Business Overview
13.4.5 Bontac Latest Developments
13.5 Longer Livetech
13.5.1 Longer Livetech Company Information
13.5.2 Longer Livetech Nicotinamide Riboside (NR) Product Portfolios and Specifications
13.5.3 Longer Livetech Nicotinamide Riboside (NR) Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Longer Livetech Main Business Overview
13.5.5 Longer Livetech Latest Developments
13.6 Tiantai Biotechnology
13.6.1 Tiantai Biotechnology Company Information
13.6.2 Tiantai Biotechnology Nicotinamide Riboside (NR) Product Portfolios and Specifications
13.6.3 Tiantai Biotechnology Nicotinamide Riboside (NR) Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Tiantai Biotechnology Main Business Overview
13.6.5 Tiantai Biotechnology Latest Developments
13.7 EnzymeWorks
13.7.1 EnzymeWorks Company Information
13.7.2 EnzymeWorks Nicotinamide Riboside (NR) Product Portfolios and Specifications
13.7.3 EnzymeWorks Nicotinamide Riboside (NR) Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 EnzymeWorks Main Business Overview
13.7.5 EnzymeWorks Latest Developments
13.8 Suzhou MyLand Pharm & Nutrition
13.8.1 Suzhou MyLand Pharm & Nutrition Company Information
13.8.2 Suzhou MyLand Pharm & Nutrition Nicotinamide Riboside (NR) Product Portfolios and Specifications
13.8.3 Suzhou MyLand Pharm & Nutrition Nicotinamide Riboside (NR) Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Suzhou MyLand Pharm & Nutrition Main Business Overview
13.8.5 Suzhou MyLand Pharm & Nutrition Latest Developments
13.9 Shenzhen Ejion Biotechnology
13.9.1 Shenzhen Ejion Biotechnology Company Information
13.9.2 Shenzhen Ejion Biotechnology Nicotinamide Riboside (NR) Product Portfolios and Specifications
13.9.3 Shenzhen Ejion Biotechnology Nicotinamide Riboside (NR) Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Shenzhen Ejion Biotechnology Main Business Overview
13.9.5 Shenzhen Ejion Biotechnology Latest Developments
13.10 Zhejiang Jiahua
13.10.1 Zhejiang Jiahua Company Information
13.10.2 Zhejiang Jiahua Nicotinamide Riboside (NR) Product Portfolios and Specifications
13.10.3 Zhejiang Jiahua Nicotinamide Riboside (NR) Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Zhejiang Jiahua Main Business Overview
13.10.5 Zhejiang Jiahua Latest Developments
13.11 Weitai Pharmaceutical
13.11.1 Weitai Pharmaceutical Company Information
13.11.2 Weitai Pharmaceutical Nicotinamide Riboside (NR) Product Portfolios and Specifications
13.11.3 Weitai Pharmaceutical Nicotinamide Riboside (NR) Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 Weitai Pharmaceutical Main Business Overview
13.11.5 Weitai Pharmaceutical Latest Developments
14 Research Findings and Conclusion